VANCOUVER, April 23, 2018 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter ended March 31, 2018, on Monday, April 30, 2018 after market close.
VANCOUVER, April 23, 2018 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter ended March 31, 2018, on Monday, April 30, 2018 after market close.
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on received a notification letter from...
Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on received a notification letter from...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic mathematical modeling, simulation, and analysis to de-risk therapeutic research and development, today announced a collaboration with...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Medical Device Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com'...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Medical Device Market Report: Trends, Forecast and Competitive Analysis" report has been added to ResearchAndMarkets.com'...
Today, Kroger (NYSE: KR) and Cardinal Health (NYSE: CAH) announced the companies will host joint drug take-back events at more than 100 Kroger Family of Pharmacies locations from 10 a.m. – 2 p.m. local time on April 28,...
Today, Kroger (NYSE: KR) and Cardinal Health (NYSE: CAH) announced the companies will host joint drug take-back events at more than 100 Kroger Family of Pharmacies locations from 10 a.m. – 2 p.m. local time on April 28,...
Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to...
Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, announced today that it has entered into an asset purchase agreement with Nalpropion Pharmaceuticals, Inc. to...
This report analyzes the worldwide markets for Patient Scales in US$ Thousand by the following Product Segments: Floor Scales, Infant & Baby Scales, Chair Scales, and Under Bed Scales. Download the full report:...
This report analyzes the worldwide markets for Patient Scales in US$ Thousand by the following Product Segments: Floor Scales, Infant & Baby Scales, Chair Scales, and Under Bed Scales. Download the full report:...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Surgical Drapes and Gowns Market by Type (Drapes, Gown), Utility (Reusable, Disposable), End User (Hospital) - Global Foreca...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 23, 2018 /PRNewswire/ -- The "Surgical Drapes and Gowns Market by Type (Drapes, Gown), Utility (Reusable, Disposable), End User (Hospital) - Global Foreca...
Demonstrating its advanced manufacturing technologies and an innovative approach to custom manufacturing, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., will attend NPE 2018: The Plastics...
Demonstrating its advanced manufacturing technologies and an innovative approach to custom manufacturing, Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., will attend NPE 2018: The Plastics...
Allergy relief brand to help allergy sufferers share how they really feel
Allergy relief brand to help allergy sufferers share how they really feel
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at the 28th European Congress of...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that positive new data from multiple studies of VIBATIV® (telavancin) were presented at the 28th European Congress of...
Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership of Grünenthal's research and development...
Grünenthal announced today that Philip Just Larsen has been appointed Chief Scientific Officer (CSO) and Member of the Corporate Executive Board. He will assume leadership of Grünenthal's research and development...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Darling Ingredients Inc. (NYSE: DAR) ("Darling" or the "Company") today announced that Darling Global Finance B.V. (the "Issuer"), an indirect, wholly-owned subsidiary of the Company incorporated under the laws of The...
Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone, with 90% occurring in Africa. Toshihiro Mita from the Juntendo University...
Annual deaths from malaria are decreasing, but the disease is still a global health problem, with 216 million new cases estimated in 2016 alone, with 90% occurring in Africa. Toshihiro Mita from the Juntendo University...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the results of key secondary outcome measures from Phase 3 clinical trials (BHV3000-301 and BHV3000-302) of rimegepant, the first oral CGRP receptor...
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced the results of key secondary outcome measures from Phase 3 clinical trials (BHV3000-301 and BHV3000-302) of rimegepant, the first oral CGRP receptor...
Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including...
Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including...
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual...
Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual...
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018.
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018.
Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in...
Eli Lilly and Company (NYSE: LLY) today announced additional results from its global, randomized, double-blind, placebo-controlled Phase 3 RANGE trial evaluating CYRAMZA® (ramucirumab) in combination with docetaxel in...
Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, will deliver a mini-oral presentation and two additional posters at the European Congress...
Iterum Therapeutics plc, a clinical-stage pharmaceutical company developing anti-infectives against multi-drug resistant pathogens, will deliver a mini-oral presentation and two additional posters at the European Congress...
Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the American Academy of Neurology (AAN) which will focus on neuromuscular medical...
Global biotherapeutics leader CSL Behring today announced that it will host an Industry Therapeutic Update at the 2018 annual meeting of the American Academy of Neurology (AAN) which will focus on neuromuscular medical...
Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company's supplemental New Drug Application (sNDA) which seeks a new indication for...
Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company's supplemental New Drug Application (sNDA) which seeks a new indication for...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Bruker Corporation 60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Ad...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Bruker Corporation 60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Ad...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 20, 2018 /PRNewswire/ -- The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offe...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 20, 2018 /PRNewswire/ -- The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offe...
High-accuracy multi-wavelength digital refractometer with the V-block method, optimal for measurements of optical materials Shimadzu Corporation has released the KPR-300 Kalnew precision refractometer in North America....
High-accuracy multi-wavelength digital refractometer with the V-block method, optimal for measurements of optical materials Shimadzu Corporation has released the KPR-300 Kalnew precision refractometer in North America....
Heidelberg University Hospital in Germany has entered into a partnership with RaySearch Laboratories AB (publ) to pioneer the RayCare™ oncology information system. The research partnership, which focuses on supporting...
Heidelberg University Hospital in Germany has entered into a partnership with RaySearch Laboratories AB (publ) to pioneer the RayCare™ oncology information system. The research partnership, which focuses on supporting...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
Hologic, Inc. (Nasdaq: HOLX) announced today that in a new study, women treated with NovaSure® endometrial ablation reported a higher one-year amenorrhea (absence of menstruation) rate, better quality of life (QoL)...
The "Pharma E-commerce Market in Europe 2018-2022" report has been added to ResearchAndMarkets.com's offering. The pharma e-commerce market in Europe to grow at a CAGR of 13.82% during the period 2018-2022. Pharma...
The "Pharma E-commerce Market in Europe 2018-2022" report has been added to ResearchAndMarkets.com's offering. The pharma e-commerce market in Europe to grow at a CAGR of 13.82% during the period 2018-2022. Pharma...
Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published results from a Phase 3, randomized, head-to-head efficacy study that found an...
Seqirus, a CSL company (ASX: CSL) and a leading innovator in influenza vaccines, today announced that The Lancet Respiratory Medicine published results from a Phase 3, randomized, head-to-head efficacy study that found an...
This report analyzes the worldwide markets for Operating Tables in US$ Thousand by the following Product Segments: General Operating Tables, and Specialty Operating Tables. Download the full report:...
This report analyzes the worldwide markets for Operating Tables in US$ Thousand by the following Product Segments: General Operating Tables, and Specialty Operating Tables. Download the full report:...
This report analyzes the worldwide markets for Intravenous Equipment in US$ Thousand by the following Segments: Intravenous Catheters, and Intravenous Infusion Pumps and Sets. Download the full report:...
This report analyzes the worldwide markets for Intravenous Equipment in US$ Thousand by the following Segments: Intravenous Catheters, and Intravenous Infusion Pumps and Sets. Download the full report:...
The global optical microscopes market was valued at around US$ 1.5 Bn in 2016 and is anticipated to expand at a CAGR of around 6% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR)...
The global optical microscopes market was valued at around US$ 1.5 Bn in 2016 and is anticipated to expand at a CAGR of around 6% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR)...
Eisai Inc. will present six posters on FYCOMPA® (perampanel) CIII at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles from April 21-27. The poster presentations will include analyses on long-term...
Eisai Inc. will present six posters on FYCOMPA® (perampanel) CIII at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles from April 21-27. The poster presentations will include analyses on long-term...
Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today Sanofi purchased the Beacon platform to accelerate their cell line...
Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today Sanofi purchased the Beacon platform to accelerate their cell line...
Global sales and marketing firm ZS is excited to announce a new partnership with Valkre Solutions, an account-based sales and marketing cloud software provider. ZS will leverage Valkre's software to transform the...
Global sales and marketing firm ZS is excited to announce a new partnership with Valkre Solutions, an account-based sales and marketing cloud software provider. ZS will leverage Valkre's software to transform the...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey....
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey....
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have...
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved TAGRISSO® (osimertinib) for the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have...
BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector. The majority of...
BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector. The majority of...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive...
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive...
Global Circular Dichroism (CD) Spectrometers Market: Overview Circular dichroism (CD) spectrometer is an analytical instrument used to analyze the molecular structure and chiral activity of organic molecules.It is widely...
Global Circular Dichroism (CD) Spectrometers Market: Overview Circular dichroism (CD) spectrometer is an analytical instrument used to analyze the molecular structure and chiral activity of organic molecules.It is widely...
Once-daily Xultophy® has been shown to help patients achieve blood glucose targets
Once-daily Xultophy® has been shown to help patients achieve blood glucose targets
Softheon, a national leader in cloud-based health insurance exchange integration and services, announced today its private-label enrollment solution, which provides Enhanced Direct Enrollment-as-a-service (EDE); a unified...
Softheon, a national leader in cloud-based health insurance exchange integration and services, announced today its private-label enrollment solution, which provides Enhanced Direct Enrollment-as-a-service (EDE); a unified...
Howard University Hospital's (HUH) Department of Trauma and Critical Care recently teamed up with staff members at H.D. Woodson Senior High School in Washington, D.C., to conduct a "Stop the Bleed" Training.
Howard University Hospital's (HUH) Department of Trauma and Critical Care recently teamed up with staff members at H.D. Woodson Senior High School in Washington, D.C., to conduct a "Stop the Bleed" Training.
According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Material Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use...
According to a new report published by Allied Market Research, titled, "Single-use Bioprocessing Material Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global single-use...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 18, 2018 /PRNewswire/ -- The "Endoscopy Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. Gastrointest...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 18, 2018 /PRNewswire/ -- The "Endoscopy Devices - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. Gastrointest...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Xencor to perform...
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Xencor to perform...
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease...
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical...
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced preclinical...
Navigator Business Solutions, an SAP implementation Gold Partner, has just released a pair of turnkey ERP solutions tailored specifically for medical device and pharmaceutical manufacturers.
Navigator Business Solutions, an SAP implementation Gold Partner, has just released a pair of turnkey ERP solutions tailored specifically for medical device and pharmaceutical manufacturers.
The global X-Ray Photoelectron Spectroscopy (XPS) Market was valued at USD 439.64 million in 2014 and is expected to reach USD 712.4 million by 2022, with a CAGR of 6.2%. XPS is a surface-sensitive measureable...
The global X-Ray Photoelectron Spectroscopy (XPS) Market was valued at USD 439.64 million in 2014 and is expected to reach USD 712.4 million by 2022, with a CAGR of 6.2%. XPS is a surface-sensitive measureable...
The "Integrated Devices for Reconstituting Injectables" report has been added to ResearchAndMarkets.com's offering. The inherent instability of biological drugs is a limitation that has a direct impact on the drug...
The "Integrated Devices for Reconstituting Injectables" report has been added to ResearchAndMarkets.com's offering. The inherent instability of biological drugs is a limitation that has a direct impact on the drug...
STEERLife, provider of technology platforms and process solutions for pharmaceutical industry, announced a partnership with the Center for Structured Organic Particulate Systems (C-SOPS), USA, to foster transformation of...
STEERLife, provider of technology platforms and process solutions for pharmaceutical industry, announced a partnership with the Center for Structured Organic Particulate Systems (C-SOPS), USA, to foster transformation of...
The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 14.64% during the forecast period....
The global single-cell genome sequencing market size is expected to reach USD 2.49 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 14.64% during the forecast period....
During its annual Spring Gala at The Plaza Hotel last Tuesday evening, American Skin Association (ASA) Chairman, Howard P. Milstein, announced the Abby S. and Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma...
During its annual Spring Gala at The Plaza Hotel last Tuesday evening, American Skin Association (ASA) Chairman, Howard P. Milstein, announced the Abby S. and Howard P. Milstein Innovation Award for Melanoma/Non-Melanoma...
BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of 10 abstracts describing progress on translational preclinical data on display at the...
BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the presentation of 10 abstracts describing progress on translational preclinical data on display at the...
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved TAVALISSE™ (fostamatinib disodium hexahydrate) for the treatment of thrombocytopenia in adult patients...
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that the U.S. Food and Drug Administration (FDA) approved TAVALISSE™ (fostamatinib disodium hexahydrate) for the treatment of thrombocytopenia in adult patients...
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that...
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced that...
Chairman Aderholt, Ranking Member Bishop, and Members of the Subcommittee. I'd like to thank the Committee for your commitment to FDA. We've been fortunate to receive strong bipartisan support in recent years. And...
Chairman Aderholt, Ranking Member Bishop, and Members of the Subcommittee. I'd like to thank the Committee for your commitment to FDA. We've been fortunate to receive strong bipartisan support in recent years. And...
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered, dendritic cell vaccines in oncology, today presented initial open-label results from the ongoing Phase 2b clinical trial of the...
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered, dendritic cell vaccines in oncology, today presented initial open-label results from the ongoing Phase 2b clinical trial of the...
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that the Company presented a...
DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that the Company presented a...
The "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive insight into the...
The "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering. This report provides a comprehensive insight into the...
The "Medical Display Market by Technology (LED, OLED) Panel Size (=22.9, 27.0-41.9, =42) Resolution (=2MP, 4.1-8MP, =8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display...
The "Medical Display Market by Technology (LED, OLED) Panel Size (=22.9, 27.0-41.9, =42) Resolution (=2MP, 4.1-8MP, =8MP), Application (Radiology, Mammography, Digital Pathology, Multi-modality, Surgical), & Display...
The "Scintillators Market to 2025 - Global Analysis and Forecasts by Material Composition, Industries and End Products" report has been added to ResearchAndMarkets.com's offering. The scintillators market is estimated...
The "Scintillators Market to 2025 - Global Analysis and Forecasts by Material Composition, Industries and End Products" report has been added to ResearchAndMarkets.com's offering. The scintillators market is estimated...
Introduction Globally the market for micro-pump is increasing rapidly. Micro-pumps have been playing a crucial role in the pharmaceutical industry for last few years. Especially in the processes such as drug discovery,...
Introduction Globally the market for micro-pump is increasing rapidly. Micro-pumps have been playing a crucial role in the pharmaceutical industry for last few years. Especially in the processes such as drug discovery,...
Eiger BioPharmaceuticals, Inc., (NASDAQ: EIGR) today announced additional positive lonafarnib (LNF) data from the LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program presented at The International Liver...
Eiger BioPharmaceuticals, Inc., (NASDAQ: EIGR) today announced additional positive lonafarnib (LNF) data from the LOWR HDV (LOnafarnib With Ritonavir in Hepatitis Delta Virus) Program presented at The International Liver...
According to a new report published by Allied Market Research, titled, "3D medical imaging services Market by Technique, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global...
According to a new report published by Allied Market Research, titled, "3D medical imaging services Market by Technique, Application and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 17, 2018 /PRNewswire/ -- The "Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Man...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 17, 2018 /PRNewswire/ -- The "Arthroscopy Instruments Market by Type (Implants, Arthroscope, Visualization System, Surgical Shaver, RF Ablation, Fluid Man...
Torque, an immuno-oncology company developing Deep Primed™ cellular therapies with pharmacologic control to direct immune power deep within the tumor microenvironment, announced today preclinical data for the company's...
Torque, an immuno-oncology company developing Deep Primed™ cellular therapies with pharmacologic control to direct immune power deep within the tumor microenvironment, announced today preclinical data for the company's...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new data from studies of VIBATIV® (telavancin) will be presented at the 28th European Congress of Clinical...
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that new data from studies of VIBATIV® (telavancin) will be presented at the 28th European Congress of Clinical...
OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the company plans to report long-term clinical benefits in mild to severe knee osteoarthritis (OA) patients who were treated with TPX-100...
OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the company plans to report long-term clinical benefits in mild to severe knee osteoarthritis (OA) patients who were treated with TPX-100...
Anitoa Systems, ("Anitoa"), a Menlo Park CA startup since 2012, today announced the volume production release of its single chip Ultra-low-light CMOS bio-optical sensor, ULS24. Capable of 3x10-6 lux low-light detection,...
Anitoa Systems, ("Anitoa"), a Menlo Park CA startup since 2012, today announced the volume production release of its single chip Ultra-low-light CMOS bio-optical sensor, ULS24. Capable of 3x10-6 lux low-light detection,...
The "Excipients in Pharmaceuticals: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering. This report on the pharmaceutical excipient market covers an overview of excipients,...
The "Excipients in Pharmaceuticals: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering. This report on the pharmaceutical excipient market covers an overview of excipients,...
Amicrobe, Inc., a company that uses advanced bioengineering principles to develop novel antimicrobial products for the era of antibiotic resistance, today announced the recent hiring of Doug Looker, Ph.D., who will join...
Amicrobe, Inc., a company that uses advanced bioengineering principles to develop novel antimicrobial products for the era of antibiotic resistance, today announced the recent hiring of Doug Looker, Ph.D., who will join...
Unique Hologram Technology Will Showcase the Benefits Accuray Radiotherapy Systems and Software Solutions Provide to Patients Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of...
Accuray Incorporated (Nasdaq: ARAY) announced today it will be showcasing the benefits of its radiotherapy systems and software solutions at the 37th annual European Society for Radiotherapy and Oncology (ESTRO) meeting in...
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has provided full approval for Praxbind® (idarucizumab), the specific reversal agent for Pradaxa® (dabigatran etexilate mesylate)....
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has provided full approval for Praxbind® (idarucizumab), the specific reversal agent for Pradaxa® (dabigatran etexilate mesylate)....
For years, Institut Marquès, centre of international standing in Gynaecology and Assisted Reproduction, has been carrying out cutting-edge research into the effects of music on the beginning of life, during embryonic and...
For years, Institut Marquès, centre of international standing in Gynaecology and Assisted Reproduction, has been carrying out cutting-edge research into the effects of music on the beginning of life, during embryonic and...
Xcision Medical Systems, LLC today announced that Azienda Universitaria Integrata di Udine (ASUIUD) in Italy will acquire the GammaPod™ Stereotactic Radiotherapy System, a new treatment system with the potential to offer...
Xcision Medical Systems, LLC today announced that Azienda Universitaria Integrata di Udine (ASUIUD) in Italy will acquire the GammaPod™ Stereotactic Radiotherapy System, a new treatment system with the potential to offer...
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered dendritic cell cancer vaccines, today announced that new interim data from the ongoing Phase 2b clinical trial of the TLPLDC (tumor...
Elios Therapeutics, a biopharmaceutical company developing innovative particle-delivered dendritic cell cancer vaccines, today announced that new interim data from the ongoing Phase 2b clinical trial of the TLPLDC (tumor...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 16, 2018 /PRNewswire/ -- The "Global Robotic Surgery Market by Region (North America, Europe, Asia Pacific and ROW), by Product Type (Surgical Robot Syste...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 16, 2018 /PRNewswire/ -- The "Global Robotic Surgery Market by Region (North America, Europe, Asia Pacific and ROW), by Product Type (Surgical Robot Syste...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 16, 2018 /PRNewswire/ -- The "Global Mass Spectrometry Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global mas...
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com SOURCE Research and Markets DUBLIN, April 16, 2018 /PRNewswire/ -- The "Global Mass Spectrometry Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global mas...
Genomma Lab invites you to its First Quarter Conference Call and Webcast.
Genomma Lab invites you to its First Quarter Conference Call and Webcast.
GetWellNetwork®, Inc., the Precision Engagement™ health care company, announced today that Nikia Bergan has joined the company as Chief Revenue Officer.
GetWellNetwork®, Inc., the Precision Engagement™ health care company, announced today that Nikia Bergan has joined the company as Chief Revenue Officer.
MarketResearch.biz announces publication of its most recently generated research report titled, "Global Hearing Aids Market by Product Type (Behind the Ear Hearing Aids, Receiver in the Ear Hearing Aids, In the Ear...
MarketResearch.biz announces publication of its most recently generated research report titled, "Global Hearing Aids Market by Product Type (Behind the Ear Hearing Aids, Receiver in the Ear Hearing Aids, In the Ear...
PolicyManager, a scalable SaaS-based healthcare policy and procedure management platform, now supports crosswalking of policies to the CAP Accreditation Checklists
PolicyManager, a scalable SaaS-based healthcare policy and procedure management platform, now supports crosswalking of policies to the CAP Accreditation Checklists
The National Comprehensive Cancer Network® (NCCN®) recently convened a roundtable discussion on trends for delivering quality care and value for people with cancer, in the face of climbing costs. The discussion took place...
The National Comprehensive Cancer Network® (NCCN®) recently convened a roundtable discussion on trends for delivering quality care and value for people with cancer, in the face of climbing costs. The discussion took place...
Aprea Therapeutics today presented results at the 2018 AACR Annual Meeting from its ongoing Phase Ib/II clinical study in MDS. The ongoing study, sponsored by the Moffitt Cancer Center with financial support from the Evans...
Aprea Therapeutics today presented results at the 2018 AACR Annual Meeting from its ongoing Phase Ib/II clinical study in MDS. The ongoing study, sponsored by the Moffitt Cancer Center with financial support from the Evans...
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today provided highlights from its Research Reception held on Sunday, April 15, 2018, during the American...
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today provided highlights from its Research Reception held on Sunday, April 15, 2018, during the American...
InnerScope Hearing Technologies Inc. (OTCQB "INND") announced a Strategic Partnership Agreement with Advantego Corporation for exclusive worldwide distribution rights for Advantego's Intelligent Solutions Platform and...
InnerScope Hearing Technologies Inc. (OTCQB "INND") announced a Strategic Partnership Agreement with Advantego Corporation for exclusive worldwide distribution rights for Advantego's Intelligent Solutions Platform and...
Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., today announced that it has entered into an exclusive option and license agreement with Genentech, a member of the Roche Group, to develop Kineta's a9/a10...
Kineta Chronic Pain, LLC, a subsidiary of Kineta, Inc., today announced that it has entered into an exclusive option and license agreement with Genentech, a member of the Roche Group, to develop Kineta's a9/a10...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that data from a Phase 2 proof of concept clinical study of esketamine nasal spray, published in the American Journal of Psychiatry, showed that...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that data from a Phase 2 proof of concept clinical study of esketamine nasal spray, published in the American Journal of Psychiatry, showed that...
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance® on the progression of kidney disease and the...
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance® on the progression of kidney disease and the...
From the CIE Summit in San Diego, venerable clinical data exchange company 4medica continues to advance its "one patient, one record" mission. In addition to being a corporate sponsor of the conference, 4medica's...
From the CIE Summit in San Diego, venerable clinical data exchange company 4medica continues to advance its "one patient, one record" mission. In addition to being a corporate sponsor of the conference, 4medica's...
Variant Pharmaceuticals, Inc. (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today receipt of FDA minutes from the March 12, 2018 Pre-IND meeting...
Variant Pharmaceuticals, Inc. (Variant), a clinical stage orphan drug company developing first-in-class drugs for patients with rare diseases, announced today receipt of FDA minutes from the March 12, 2018 Pre-IND meeting...
Phase I data show early efficacy in the majority of patients and a very favourable safety profile Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting...
Phase I data show early efficacy in the majority of patients and a very favourable safety profile Apitope, a clinical stage biotech company developing potential first-in-class antigen-specific immunotherapies targeting...
Nektar Therapeutics (Nasdaq: NKTR) today announced that it is presenting new preclinical data for its immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting 2018. Nektar researchers...
Nektar Therapeutics (Nasdaq: NKTR) today announced that it is presenting new preclinical data for its immuno-oncology programs at the American Association for Cancer Research (AACR) Annual Meeting 2018. Nektar researchers...
DNAtix has completed the first Proof Of Concept (POC) test by transferring the complete genome sequence of a virus - Enterobacteria phage phiX174 sensu lato - over the Ethereum Blockchain. The bacteria phage, a...
DNAtix has completed the first Proof Of Concept (POC) test by transferring the complete genome sequence of a virus - Enterobacteria phage phiX174 sensu lato - over the Ethereum Blockchain. The bacteria phage, a...
Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the online publication of preclinical and...
Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the online publication of preclinical and...
Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced proof-of-concept data from the ongoing Phase 1...
Blueprint Medicines Corporation (NASDAQ:BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced proof-of-concept data from the ongoing Phase 1...
The work of the Stand Up To Cancer-St. Baldrick's Foundation Pediatric Cancer Dream Team, launched in 2013 to help develop new immunotherapy approaches to high-risk childhood cancers, will continue with a commitment of...
The work of the Stand Up To Cancer-St. Baldrick's Foundation Pediatric Cancer Dream Team, launched in 2013 to help develop new immunotherapy approaches to high-risk childhood cancers, will continue with a commitment of...
